ChanTest (acquired by Charles River) is an ion channel-focused company providing both drug safety and drug discovery and development assays for commercial clients. The company features the most extensive library of ion channel-expressing cell lines available on the market. In addition to its service business, the company has recently added a product line offering high-value reagents such as specific ion channel-expressing cells for customer-specific applications.
Read the Case Study

News: Acquisition Enhances Ion Channel Drug Discovery Capabilities